Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)

Summary

The present study was conceived to evaluate the effects of levosimendan on cardiopulmonary exercise test (CPET) and DLCO ( Diffusion capacity of Lung for carbon monoxide) in patients with severe heart failure in stable clinical conditions (NYHA - New York Heart Association - class III, with a peak VO2 (Oxygen consumption ) \< 12 ml/min/kg) on top of optimized standard therapy.

Timeline

Start

2012-09

Primary completion

2014-09

Completion

2014-12

Drugs

Indications